Viewing Study NCT04575961


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2025-12-27 @ 9:28 PM
Study NCT ID: NCT04575961
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-23
First Post: 2020-09-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer
Sponsor: North Eastern German Society of Gynaecological Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module